ALONGI, Filippo
 Distribuzione geografica
Continente #
NA - Nord America 12.743
EU - Europa 6.748
AS - Asia 1.669
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 13
OC - Oceania 8
SA - Sud America 3
Totale 21.199
Nazione #
US - Stati Uniti d'America 12.701
DE - Germania 1.856
PL - Polonia 1.434
UA - Ucraina 1.313
CN - Cina 903
GB - Regno Unito 660
HK - Hong Kong 619
RU - Federazione Russa 559
IE - Irlanda 327
FI - Finlandia 221
IT - Italia 199
SE - Svezia 98
VN - Vietnam 74
CA - Canada 40
TR - Turchia 31
BE - Belgio 21
FR - Francia 16
IN - India 16
EU - Europa 15
GR - Grecia 10
NL - Olanda 10
AU - Australia 7
SG - Singapore 6
CH - Svizzera 5
MA - Marocco 5
MU - Mauritius 5
PT - Portogallo 4
CI - Costa d'Avorio 3
IL - Israele 3
IR - Iran 3
JP - Giappone 3
AT - Austria 2
BD - Bangladesh 2
MK - Macedonia 2
PH - Filippine 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 21.199
Città #
Fairfield 2.569
Warsaw 1.434
Woodbridge 1.209
Ashburn 1.145
Jacksonville 1.065
Seattle 951
Cambridge 925
Houston 882
Wilmington 831
Hong Kong 610
Princeton 610
Chandler 564
Ann Arbor 411
Dublin 319
Nanjing 232
New York 216
Helsinki 201
Dearborn 136
Des Moines 132
Beijing 124
San Diego 123
Nürnberg 100
Nanchang 85
London 75
Dong Ket 74
Changsha 68
Hebei 53
Jinan 53
Jiaxing 51
Shenyang 45
Brescia 35
Tianjin 29
Kocaeli 28
Orange 28
Kilburn 26
Kunming 26
North York 25
Westminster 25
Hangzhou 22
Shanghai 22
Brussels 19
Lappeenranta 17
West Jordan 16
Norwalk 15
San Francisco 12
Toronto 12
Hounslow 11
Phoenix 11
Zhengzhou 11
Chiswick 10
Haikou 10
Milan 10
Pune 10
Lanzhou 9
New Bedfont 9
Hanover 8
Ningbo 8
Rome 8
Taizhou 8
Athens 7
Chiari 7
Palazzolo sull'Oglio 6
Redwood City 6
Taiyuan 6
Wandsworth 6
Changchun 5
Florence 5
Guangzhou 5
Los Angeles 5
Southwark 5
Washington 5
Acton 4
Boardman 4
Brooklyn 4
Canberra 4
Falkenstein 4
Frankfurt am Main 4
Islington 4
Napoli 4
Amsterdam 3
Anzio 3
Ardabil 3
Asolo 3
Gragnano 3
Hefei 3
Lancaster 3
Lviv 3
Nuremberg 3
Orzivecchi 3
Prescot 3
Redmond 3
Sabbioneta 3
Sant'Ambrogio di Valpolicella 3
Secaucus 3
Settat 3
Strasbourg 3
Suzzara 3
Andover 2
Bergamo 2
Chengdu 2
Totale 15.933
Nome #
Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results 220
Postoperative breast radiotherapy after neoadjuvant chemotherapy: which uncertainties still remain? 219
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: Role of local treatments 218
SBRT and extreme hypofractionation: A new era in prostate cancer treatments? 212
Dose-volumerelated dysphagia after constrictor muscles definition in head and neck cancer intensitymodulated radiation treatment 210
Radiotherapy in patients with connective tissue diseases 204
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist 202
Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold 192
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique 191
Real-time intra-fraction motion management in breast cancer radiotherapy: Analysis of 2028 treatment sessions 158
1.5 T MR-guided and daily adapted SBRT for prostate cancer: Feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 157
ONE SHOT - single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I/II trial 155
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 155
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 152
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 146
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 142
Radiotherapy in patients with HIV: current issues and review of the literature 138
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 136
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 134
Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039. 133
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 131
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 128
An update on radiation therapy in head and neck cancers 127
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study 126
Role of radiosurgery/stereotactic radiotherapy in oligometastatic disease: Brain oligometastases 124
MR-guidance in clinical reality: Current treatment challenges and future perspectives 123
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment 123
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 120
Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer 118
What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review 118
Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system 116
Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer. 114
Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology 113
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 113
Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: Is it an underestimated phenomenon A radiation oncologist's perspective 112
Technical Note: Correction for intra-chamber dose gradients in reference dosimetry of flattening-filter-free MV photon beams 112
Stereotactic precision and conventional radiotherapy evaluation (SPACE)-Trial for medically inoperable Stage I NSCLC: A lost opportunity? 112
Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases 112
Watch-and-wait versus surgical resection for patients with rectal cancer 111
(Ga-68)-PSMA-PET/CT for the detection of postoperative prostate cancer recurrence: Possible implications on treatment volumes for radiation therapy 110
Stereotactic radiosurgery for patients with brain metastases 108
Extreme hypofractionation for early prostate cancer: Biology meets technology 107
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 107
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 107
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. 106
Cancer Therapy combining high-intensity focused ultrasound and megavoltage radiation 106
18F-sodium fluoride PET-CT for the assessment of brain metastasis from lung Adenocarcinoma 106
[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 106
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 105
Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma 105
Personalized - Not omitted - Radiation oncology for breast cancer 105
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 104
Choline-PET in prostate cancer management: The point of view of the radiation oncologist 104
Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study 103
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 102
Cone-beam computed tomography in lung stereotactic ablative radiation therapy: Predictive parameters of early response 102
Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients 102
Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity 102
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 102
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 102
Consolidative local therapy in oligometastatic patients 101
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature. 101
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity 101
Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis 100
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature 100
Regarding Ening et al. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification 100
A plethora of therapeutic opportunities for elderly patients with cancer: A nontrivial choice 100
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 99
Neuroendocrine carcinoma of the breast: Current evidence and future perspectives 99
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: A potential comparison bias 98
Crowd knowledge based community in radiotherapy: In response to Yartev et al 98
Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of life 98
The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy 98
Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost 98
Low-dose bath with volumetric modulated arc therapy in breast cancer: "much ado about nothing?" 97
Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience 96
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy 96
The BUONGIORNO project: Burnout syndrome among young italian radiation oncologists 96
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: Dosimetric impact of an increased near-maximum target dose and of a rectal spacer 96
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 95
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 95
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 95
Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal? 95
Stereotactic radiosurgery for intracranial metastases: Linac-based and gamma-dedicated unit approach 95
What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria 94
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 94
From radiobiology to technology: What is changing in radiotherapy for prostate cancer 94
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 94
Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy 93
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients 93
Sequential boost in neoadjuvant irradiation for T3N0-1 rectal cancer: Long-term results from a single-center experience 93
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. 92
Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur Urol 2014;65:546-51 92
Nasal cavity reirradiation: A challenging case for comparison between proton therapy and volumetric modulated arc therapy 92
What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients? 90
Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis 90
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 90
Optimal local control and tolerability of three-dimensional conformal radiation therapy in prostate cancer: A single institutional experience of dose escalation in 125 patients 89
Impact of 18F-choline PET/CT in the decision-making strategy of treatment volumes in definitive prostate cancer volumetric modulated radiation therapy 88
Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: A single-institution analysis of 1176 patients. eur urol 2014;66:1024-30 88
Totale 11.741
Categoria #
all - tutte 108.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.136 0 0 0 0 0 0 0 0 0 0 628 508
2019/20206.592 705 281 285 537 399 853 717 694 525 842 329 425
2020/20215.670 155 640 395 712 347 605 290 682 408 720 376 340
2021/20222.185 164 407 63 144 18 155 121 215 117 201 158 422
2022/20231.840 359 34 46 145 125 501 6 182 263 25 73 81
2023/20241.656 121 56 120 165 84 300 65 65 622 56 2 0
Totale 21.659